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Wnt/b-catenin target gene conductinwere
detected inmany human SCCs. Following
knockdown of b-catenin expression by
short hairpin RNA, tumor growth of human
SCC13 cell lines was reduced in xeno-
grafts, suggesting that b-catenin signaling
is required for tumorigenesis. However,
as noted by the authors, nuclear b-catenin
expression is not strictly a marker of
CSCs, and CD34 is not expressed in hu-
man SCCs, precluding a CSC analysis of
human tumors. In the human hair follicle,
CD34 immunoreactivity is found below
the bulge; however, there is no evidence
that this marker enriches for stem cells.
Several markers have been reported to
enrich for human interfollicular stem cells,
including high expression of b1 integrin,
high expression of a6 integrin (in combi-
nation with low levels of CD71), and
expression ofmelanoma-associatedchon-
droitin sulfate proteoglycan or Lrig1. In the
human hair follicle, CD200-positive bulge
cells have a high clonogenic-forming ca-
pacity in vitro, a characteristic associated
with stem cells (Ohyama et al., 2006).
Therefore, in future studies it will be useful
to determine whether any of these
markers identify CSCs within human epi-
dermal tumors.
In summary, Malanchi and colleagues
(Malanchi et al., 2008) elegantly demon-
strate that murine cutaneous tumors con-
tain a subpopulation of CSCs that can be
enriched by selection for the follicular
bulge cell surface marker, CD34. They
provide convincing evidence that b-cate-
nin signaling is required for growth of
murine squamous cell carcinomas, most
likely via the maintenance of CSCs, al-
though the mechanism by which this
occurs is still unclear. Finally, they dem-
onstrate that the Wnt/b-catenin pathway
also is activated in human malignant
SCCs. However, the challenge remains
to identify CSCs within human epidermal
tumors. These studies are reminiscent of
the role that the Wnt/b-catenin pathway
plays in modulating stem cell mainte-
nance and tumorigenesis in the intestinal
tract, suggesting that therapeutic inter-
ventions targeting this pathway may be
beneficial in multiple epithelial tissues
(Reya and Clevers, 2005).
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In this issue of Cell Stem Cell, Efroni et al. (2008) use tiling microarrays to reveal genome-wide hypertran-
scription in mouse embryonic stem cells (ESCs), including expression of normally silent, noncoding regions.
Hypertranscription may reflect the unusual ‘‘open’’ structure of ESC chromatin.By several criteria, ESC nuclear DNA is
packaged in an unusual form of chromatin
that appears to be more ‘‘open’’ than that
in differentiated cells. Histones and non-
histone proteins exchange more rapidly,
i.e., are more loosely bound to DNA, in
ESCs (Meshorer et al., 2006), their consti-
tutive heterochromatin is more dispersed,
or at least less prominent microscopically
(Meshorer et al., 2006; Spivakov and
Fisher, 2007), and the positioning of genes408 Cell Stem Cell 2, May 2008 ª2008 Elsevand chromosome territories changes
markedly on ESC differentiation (Gia-
drossi et al., 2007). ESCs also exhibit
global enrichment of histone modifica-
tions associatedwith transcriptional activ-
ity as well as depletion of modifications
associated with silent chromatin (Spiva-
kov and Fisher, 2007). Meshorer, Misteli,
and colleagues (Efroni et al., 2008) now
provide further evidence for the open
structure of ESC chromatin and go on toier Inc.ask whether it might be associated with
altered transcription.
In their analyses, Efroni et al. (2008) uti-
lize whole-genome tiling arrays to com-
pare transcript levels in the R1 ESC line
to those present in their differentiated
progeny. In ESCs, transcription was de-
tected in intronic, intergenic, and exonic
regions, with over-threshold readings
from just over one-million probes. In con-
trast, the number of positive probes was
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entiated for 7 days in culture to yield neu-
ral progenitor cells (NPCs). A less exten-
sive reduction in positive probes was
detected after only 24 hr and occurred
while the population was still proliferating
rapidly, an important consideration as the
unusual cell cycle of ESCs (most are in S
phase) differsmarkedly from that ofNPCs.
Importantly, changes detected during dif-
ferentiation were not limited to complete
loss of expression of selected regions.
Comparing relative change in the expres-
sion level of all individual probes that
remained positive after differentiation re-
vealed that far more were downregulated
in differentiated cells than were elevated
during this process. The authors note
that the net change in transcription (mea-
sured by relative numbers of down- and
upregulated probes) varied widely from
one chromosome to another. Some
chromosomes (e.g., 6, 7, X) exhibited
a several-fold excess of downregulated
probes, whereas others showed a much
smaller difference or even a slight excess
of upregulated probes (e.g., 1, 12). By
eye, the relative numbers of upregulated
and downregulated probes within inter-
genic and exonic regions of any given
chromosome appear correlated, suggest-
ing that differences observed between
individual chromosomes may not be due
entirely to different numbers of tissue-
specific genes. Could these findings re-
flect, in part at least, differences in the
stage at which individual chromosome
territories are remodeled as differentiation
proceeds?
A reasonable working hypothesis is
that global hypertranscription in ESCs
is a consequence of their unusually open
chromatin structure, thus allowing easier
access to transcription factors and the
transcriptional machinery. ESC chromatin
may be in a ‘‘ground state’’ that permits
progression toward multiple distinct dif-
ferentiation pathways, as directed by in-
trinsic or extrinsic signals (Silva and
Smith, 2008). However, transcript abun-
dance (the primary measure of transcrip-
tion used by Efroni et al. [2008]) may
also be influenced by posttranscriptional
events, including RNA processing, trans-
port, and even ribosome loading, all of
which will change during differentiation
(e.g., Sampath et al., 2008, this issue of
Cell Stem Cell). The relative contributions
of these various processes to regulationof transcript levels require further explora-
tion.
ESC differentiation involves not only al-
tered gene expression patterns but also
remodeling and repositioning of chromo-
some territories and changes in replication
timing (Azuara et al., 2006). These events
are all likely to be facilitated by an initially
open, ‘‘plastic’’ chromatin state, raising
the possibility that hypertranscription is
simply a byproduct of a necessary chro-
matinconformationandof nospecificcon-
sequence in itself. To explore this, Efroni
et al. (2008) analyzed expression of the an-
notated genes on the tiling array. Expres-
sion of 54% of these genes was elevated
in ESCs relative to NPCs, 38% were re-
duced, and only 8% were classed as
unchanged. Of all the relatively overex-
pressed genes in ESCs, the expression
level of general transcription factors and
chromatin remodeling proteins was signif-
icantly elevated. Could the relatively high
expression of chromatin remodelers in
undifferentiated ESCs be responsible for
their unusual chromatin conformation and
persistence of the pluripotent state? To
test this, three highly expressed remodel-
ers, Brg1, Chd1l, and Smarcd2, were
knocked down individually. The effects
were mixed. Smarcd2 knockdown pro-
duced no phenotype, whereas diminution
of Chd1l and Brg1 expression reduced
growth rate. However, only loss of Brg1
also compromised differentiation capacity
of ESCs into nexin-positive neural progen-
itors. Further work is needed to address
thepotential rolesofchromatin remodeling
proteins, initially by determining whether
altered transcript levels generate altered
amounts of functional protein product.
A recent publication provides a good
illustration of how chromatin modifying
enzymes can exert both global and local
gene-specific effects (Loh et al., 2007).
Knocking down the histone demethylases
Jmjd1a and Jmjd2c in mouse ESCs glob-
ally increased the levels, respectively, of
H3 di- and trimethylated at lysine 9. These
histone modifications are typically associ-
ated with silent chromatin. In addition to
their global effects, Jmjd1a and Jmjd2c
were shown to target, and regulate, spe-
cific genes, including Tcl1, a potential reg-
ulator of self-renewal, and Nanog, a key
determinant of pluripotency. Thus, we
can see the beginnings of a network in
which key chromatin modifying enzymes
exert both global and gene-specificCell Stemeffects, which in turn influence differentia-
tion. Further, both demethylase genes
were themselves positively regulated by
the transcription factor Oct4, providing an
example of how a transcription factor can
trigger genome-wide epigenetic changes
by altering the expression of histone
modifying enzymes. It will be interesting
to seewhether differentiated cells induced
to become pluripotent by the combined
transduction of several transcription fac-
tors, including Oct4 (Jaenisch and Young,
2008), also exhibit an open chromatin
structure and hypertranscription.
A chromatin state inwhich gene expres-
sion controls are relaxed and levels of ad-
ventitious transcription increased would
seem likely to disrupt the orderly se-
quence of epigenetic events necessary
for development. Thus, it is important
that hypertranscription and open chroma-
tin do not bring with them a complete loss
of transcriptional control. Transcription of
many genes is effectively suppressed in
ESCs, often byPcGproteinswith a conse-
quent increase in H3K27me3, but this can
be reversed by depleting the relevant
methyltransferase, demonstrating that
plasticity is retained (Azuara et al., 2006).
Also, the endogenous pluripotent epiblast
cells from which cultured ESCs are de-
rived exist for only a short developmental
window, after which pluripotency is lost
(Silva and Smith, 2008). Perhaps relaxed
transcriptional control can be tolerated
in vivo for this short period. We should
also remember that ESCs derived from
this transient pluripotent population are
adapted to growth in tissue culture, a pro-
cess that exerts strong selection pressure
in favor of rapidly proliferating cells; it may
be that the unusual chromatin structure of
ESCs reflects, in part, their adaptation to
culture. Indeed, initial comparisons of the
epigenetic properties of a few silenced
genes inESCsand inner cellmass indicate
that histonemodifications associatedwith
silencing are comparatively low in ESCs,
consistentwith a relaxation in thesilencing
signal (O’Neill et al., 2006). Amoredetailed
comparison of the transcriptomes and
epigenetic properties of ESCs and the
epiblast population from which they are
derived will help answer this question.
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Systems biology studies have reveal
onic stem cell (ESC) function. In this i
is also differentially controlled in und
Pluripotent embryonic stem cells (ESCs)
have the capacity to differentiate into all
adult cell lineages and thus offer much
hope for cell-based therapies of human
disease. However, to devise and optimize
protocols to engineer ESC-derived tis-
sues requires a comprehensive under-
standing of the networks controlling ESC
fate decisions. Because ESC differentia-
tion involves changes in numerous tran-
scriptional networks (Walker et al., 2007;
Ivanova et al., 2006), protein signaling
networks (Wang et al., 2006), and chro-
matin structure (Mikkelsen et al., 2007;
Pan et al., 2007), a systems biology
approach that integrates the transcrip-
tome, proteome, and promoter occu-
pancy data is needed to fully describe
the process of stem cell differentiation.
Underlying these networks are highly
refined control mechanisms, such as
miRNA that modulate the transcriptome
and are important for ES cell self-renewal
and differentiation (Lakshmipathy et al.,
2007; Ivey et al., 2008).
Currently, there are unresolved discrep-
ancies between the transcriptome and
proteome profiles of undifferentiated
ESCs and their differentiated progeny.
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ifferentiated versus differentiated E
Specifically, the level of gene expression
does not always correlate with protein
levels observed in the same populations.
A similar disconnect between mRNA and
protein expression has been observed in
lineage-specific differentiation systems,
such as hematopoiesis and myogenesis,
and might arise via regulatory mecha-
nisms that impact translational efficiency
and protein degradation rates. To bridge
this gap, some mRNA transcripts may be
primed for translation and are termed
‘‘potentiated’’ in yeast studies. These
mRNA can be identified by the isolation
of ribosome-enriched transcripts coupled
to microarray analysis, known as transla-
tional state array analysis (TSAA).
In this issue of Cell Stem Cell, Sampath
et al. (2008) delve into the translational
control of the mouse ESC transcriptome
during differentiation. The authors first
identified that during ESC differentiation
into embryoid bodies (EBs) there is an in-
crease in global mRNA and protein syn-
thesis. Using microarray analysis, they
verified that indeed there was an increase
in global transcript abundance in differ-
entiated ESCs. Interestingly, the vast
majority of ribosomes isolated from ESCs
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were not bound to mRNA, whereas the
elevated transcript and protein levels
observed in differentiated cells were cou-
pled with a significant increase in tran-
script loading of ribosomes. Thus, the
question that arises is whether there is
preferential loading of ribosomes with
transcripts that are important for ESC dif-
ferentiation. To address this possibility,
the authors conducted TSAA, a transcrip-
tome-wide method to identify polysome-
bound transcripts. Comparing the micro-
array datasets of transcript expression
with the ribosome loading results (the
TSSA dataset), the authors distinguished
four distinct groups: (1) transcripts that
were differentially expressed and differ-
entially loaded on ribosomes, (2) tran-
scripts that were differentially expressed
but exhibited no change in translational
efficiency, (3) transcripts that were not
differentially expressed but exhibited
changes in translational efficiency, and
(4) transcripts that did not change in abun-
dance or ribosome loading. It is important
to emphasize that ‘‘differential expres-
sion’’ of transcripts refers to the combined
number of signals that were either ele-
vated or reduced beyond a set threshold
